Awiqli cleared for Type 2 diabetes

What this means

Awiqli is a weekly insulin injection that helps control blood sugar in adults with Type 2 diabetes, replacing daily basal insulin shots. The FDA just approved it as the first once-weekly insulin option for this condition. This could make treatment easier for patients who struggle with daily injections while maintaining similar blood sugar control.